Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) Earns Buy Rating from Analysts at Roth Mkm

Posted by Erica Schwartz on Jan 21st, 2025

Roth Mkm initiated coverage on shares of Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR – Get Free Report) in a note issued to investors on Tuesday,Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $10.00 price target on the stock. Roth Mkm’s target price would suggest a potential upside of 145.70% from the company’s current price.

Synergy CHC Corp. (Uplisting) Stock Down 1.9 %

Shares of Synergy CHC Corp. (Uplisting) stock opened at $4.07 on Tuesday. Synergy CHC Corp. has a one year low of $0.12 and a one year high of $10.00. The business has a 50-day moving average price of $5.20.

Insider Buying and Selling

In other Synergy CHC Corp. (Uplisting) news, CEO Jack Ross acquired 300,000 shares of the business’s stock in a transaction dated Thursday, October 24th. The shares were purchased at an average price of $9.00 per share, for a total transaction of $2,700,000.00. Following the completion of the purchase, the chief executive officer now directly owns 300,000 shares of the company’s stock, valued at $2,700,000. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

About Synergy CHC Corp. (Uplisting)

(Get Free Report)

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.